Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Xenon Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Xenon Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Xenon Pharmaceuticals Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Xenon Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Xenon Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Xenon Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Xenon Pharmaceuticals Inc.'s pipeline products Reasons to buy - Evaluate Xenon Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Xenon Pharmaceuticals Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Xenon Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Xenon Pharmaceuticals Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Xenon Pharmaceuticals Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Xenon Pharmaceuticals Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Xenon Pharmaceuticals Inc. Snapshot 5 Xenon Pharmaceuticals Inc. Overview 5 Key Information 5 Key Facts 5 Xenon Pharmaceuticals Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Xenon Pharmaceuticals Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Xenon Pharmaceuticals Inc. - Pipeline Products Glance 12 Xenon Pharmaceuticals Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Xenon Pharmaceuticals Inc. - Drug Profiles 13 Drug to Inhibit Nav1.7 for Pain 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Small Molecules for Multiple Indications 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Small Molecules to Inhibit Nav1.6 for Dravet Syndrome 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Small Molecules to Inhibit SCD-1 for Acne 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Small Molecules to Target Ion Channel for Orphan Channelopathies 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 XEN-701 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Xenon Pharmaceuticals Inc. - Pipeline Analysis 19 Xenon Pharmaceuticals Inc. - Pipeline Products by Target 19 Xenon Pharmaceuticals Inc. - Pipeline Products by Route of Administration 20 Xenon Pharmaceuticals Inc. - Pipeline Products by Molecule Type 21 Xenon Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 22 Xenon Pharmaceuticals Inc. - Recent Pipeline Updates 23 Xenon Pharmaceuticals Inc. - Dormant Projects 24 Xenon Pharmaceuticals Inc. - Locations And Subsidiaries 25 Head Office 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 27 Disclaimer 27
List of Tables Xenon Pharmaceuticals Inc., Key Information 5 Xenon Pharmaceuticals Inc., Key Facts 5 Xenon Pharmaceuticals Inc. - Pipeline by Indication, 2014 7 Xenon Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 8 Xenon Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 9 Xenon Pharmaceuticals Inc. - Out-Licensed Products in Pipeline, 2014 10 Xenon Pharmaceuticals Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 11 Xenon Pharmaceuticals Inc. - Preclinical, 2014 12 Xenon Pharmaceuticals Inc. - Pipeline by Target, 2014 19 Xenon Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 20 Xenon Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 21 Xenon Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 22 Xenon Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 23 Xenon Pharmaceuticals Inc. - Dormant Developmental Projects,2014 24
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.